Newsroom

Sorted by: Latest

-

Zefr Earns MRC Accreditation for Viewability Reporting on YouTube

LOS ANGELES--(BUSINESS WIRE)--Zefr today announced that it has been granted accreditation by the Media Rating Council (MRC) for independent third-party processing and reporting of YouTube viewability measurement via integration with Google’s Ads Data Hub (ADH), supporting Zefr’s offering of free, independent viewability reporting to advertisers. The accreditation follows a comprehensive audit conducted by an independent CPA firm engaged by the MRC. The audit evaluated Zefr’s processes, metrics,...
-

Ellington Financial Announces Redemption of Series A Preferred Stock

OLD GREENWICH, Conn.--(BUSINESS WIRE)--Ellington Financial Inc. (NYSE: EFC) (the "Company") today announced that its Board of Directors has authorized the redemption of all 4,600,000 outstanding shares of its Series A Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock (the "Series A Preferred Stock") (NYSE: EFC PR A). The anticipated redemption date is February 27, 2026 (the “Redemption Date”). The Series A Preferred Stock will be redeemed at a price equal to the liquidation preferenc...
-

Reply und Universität Mailand starten gemeinsame Forschung im Bereich des Biocomputing auf Basis der CL1-Plattform von Cortical Labs

TURIN, Italien--(BUSINESS WIRE)--Reply [EXM, STAR: REY] gibt den Beginn einer Zusammenarbeit mit der Abteilung für medizinisch-chirurgische Pathophysiologie und Transplantation der Universität Mailand bekannt. Beteiligt sind außerdem das „Centro Dino Ferrari“ der Universität Mailand sowie das „Policlinico di Milano”. Ziel der Kooperation ist eine neue Forschungs- und Versuchsinitiative im Bereich des Biocomputing. Im Rahmen des Projekts werden innovative Ansätze für Lernen und Informationsverar...
-

Reply and the University of Milan Launch Experimental Research on Biological Computing Based on Cortical Labs’ CL1 Platform

TURIN, Italy--(BUSINESS WIRE)--Reply [EXM, STAR: REY] today announced the start of a collaboration with the Department of Pathophysiology and Transplantation of the University of Milan, together with the “Centro Dino Ferrari” of the University of Milan - Ospedale Policlinico, for a new research and experimental initiative in the field of biological computing. The project aims to explore innovative approaches to learning and information processing through the integration of biological systems an...
-

Reply e Università degli Studi di Milano avviano una ricerca sperimentale sul biological computing basata sulla piattaforma CL1 di Cortical Labs

TORINO, Italia--(BUSINESS WIRE)--Reply [EXM, STAR: REY] ha annunciato oggi l'avvio di una collaborazione con il Dipartimento di Fisiopatologia e dei Trapianti dell'Università degli Studi di Milano, insieme al “Centro Dino Ferrari” dell’Università degli studi di Milano - Ospedale Policlinico, per una nuova iniziativa di ricerca e sperimentazione nel campo del biological computing, volta a esplorare approcci innovativi all'apprendimento e all'elaborazione delle informazioni attraverso l'integrazi...
-

Offerpad Appoints Rich Ford as Chief Strategy Officer & President of Cash Offer Marketplace

PHOENIX, Ariz.--(BUSINESS WIRE)--Offerpad Solutions Inc. (NYSE: OPAD), a leading real estate solutions platform, today announced that Rich Ford has joined the company as Chief Strategy Officer & President of Cash Offer Marketplace, where he will help guide Offerpad’s long-term strategy and lead the continued evolution of its marketplace-driven transaction ecosystem. Offerpad’s Cash Offer Marketplace is a strategic extension of the company’s core Cash Offer, designed to expand buyer demand b...
-

Samson Rock Capital LLP UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: SAMSON ROCK CAPITAL LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named....
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-

NATIXIS UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.   (c) Name o...